Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Urologic Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Strabismus 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Post-operative Residual Curarization 1Neuromuscular Blockade 1Endobronchial Metastases 1Emergence Delirium 1

Interventions

Saline Solution 5Sugammadex 2Sodium Chloride 2Sevoflurane 2Propofol 2Magnetic Resonance Spectroscopy 2Levetiracetam 2Fluorescein 2Dexmedetomidine 2Anesthesia, Inhalation 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1perampanel 1pegvisomant 1lorlatinib 1gadoterate meglumine 1gadobenic acid 1dexketoprofen trometamol 1clevidipine 1Trastuzumab 1Tramadol 1Temozolomide 1Positron-Emission Tomography 1Phenylephrine 1Patient-Specific Modeling 1PF-05280014 1PAVE protocol 2 1Ontruzant 1Ogivri 1Octreotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Brain Neoplasms × Sugammadex × Clear all
NCT05202899 2022-03-09

Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake Craniotomy

Guangzhou General Hospital of Guangzhou Military Command

Phase 4 Unknown
40 enrolled
CNS

Brain Neoplasms

NCT02708056 2016-03-15

Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants

Baskent University

Phase 4 Completed
26 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡